The pharmaceutical landscape is undergoing a dynamic transformation, driven by technological advancements and a renewed perspective on collaborations.

Central to this transformation is the role of CDMOs as strategic partners. In addition to providing access to the cutting-edge technologies that are reshaping drug production and supply chain management, CDMOs offer critical insights and guidance to ensure these technologies are leveraged to their maximum potential, delivering unparalleled value.
 

While advances in materials, engineering, and manufacturing processes set the stage for progress, it is the intangible elements of partnership – expertise, communication, trust, collaboration, vision, and foresight, among other — that enable teams to meet the nuanced needs of each development project, ensuring that innovation finds its way from concept to reality.

Join us as we explore how CDMOs are embracing innovation and redefining the partnership paradigm. The discussion will revolve around three pivotal developments shaping the industry's future:

• Fully flexible manufacturing solutions. Explore how CDMOs are leveraging adaptable platforms to cater to diverse production needs

• Continuous manufacturing. Understand how transitioning from batch-based to continuous processes enables enhanced product consistency, scalability, and efficiency

• Digital enablement and analytical capabilities. Discover how digital enablement is unlocking new frontiers in product quality, regulatory compliance, and operational efficiency.
   

Speaker: Anil Kane, Ph.D., MBA Global Head of Technical & Scientific Affairs, Thermo Fisher Scientific

Join us as we dive into the key considerations of choosing a CDMO as a biotech, and how to select the perfect partner:

• Establishing a pre-partner checklist of what you need (regulation, manufacturing technology, and logistics) to avoid unnecessary costly measures

• Why understanding your molecule format will help drive the process pathway for your potential partner

• Creating clear communication lines and expectations from the start

Speaker: Julien Laizé, Head of Global CTM External Manufacturing, Valneva

Join our industry expert from Roche where they delve into how CDMO’s can be set up differently to enhance their value to their customers.

• How CDMO organizations can be designed differently from the traditional way and an additional value can be realized.

• How the Lean/Agile principles can be applied to organization design.

• How the expectations from CDMOs are evolving

Speaker: Shilpl Ghosh, CDMO Site Management Chapter Lead (Infectious Disease, Immunology, Opthalmoogy), Roche

Having the right CDMO partners can provide valuable lessons in establishing successful collaborations for you and external service providers. Join and listen to the best practices in developing long- lasting relationships.

• Outlining collaborative and communication strategies that can help enhance an outsourcing partnership

• The importance of information sharing between client and vendor for effective situation response

• Case study showcase of a successfully implemented partnership strategy

Speaker: Federica Fraschetti, Associate Director - Focus Factory Leader, Merck

Finish off the day by joining our experts to understand the latest trends and developments in the CDMO space, and strategies for developing successful partnerships

• Market trends and developments in the CDMO space

• Reviewing your in-house capabilities to determine what services you need

• Best practices in optimising communication with your chosen vendor for optimal results

• When not to outsource?

Moderator
Gil Roth, President, PBOA

Panellists:

Federica Fraschetti, Associate Director - Focus Factory Leader, Merck

Shilpi Ghosh, Chapter Leader, I2O, CDMO, Roche
Anil Kane, Ph.D., MBA, Global Head of Technical & Scientific Affairs, Thermo Fisher Scientific

Raman Sehgal, Founder and Host, Molecule to Market Podcast